Cargando…
Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Pneumologia e Tisiologia
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467590/ https://www.ncbi.nlm.nih.gov/pubmed/30517345 http://dx.doi.org/10.1590/S1806-37562017000000325 |
| _version_ | 1783411290983628800 |
|---|---|
| author | da Cunha, Fernanda Sales Valle, Solange Oliveira Rodrigues Elabras, José Dortas, Sérgio Duarte França, Alfeu Tavares |
| author_facet | da Cunha, Fernanda Sales Valle, Solange Oliveira Rodrigues Elabras, José Dortas, Sérgio Duarte França, Alfeu Tavares |
| author_sort | da Cunha, Fernanda Sales |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6467590 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Sociedade Brasileira de Pneumologia e Tisiologia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64675902019-05-01 Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis da Cunha, Fernanda Sales Valle, Solange Oliveira Rodrigues Elabras, José Dortas, Sérgio Duarte França, Alfeu Tavares J Bras Pneumol Letter to the Editor Sociedade Brasileira de Pneumologia e Tisiologia 2018 /pmc/articles/PMC6467590/ /pubmed/30517345 http://dx.doi.org/10.1590/S1806-37562017000000325 Text en © 2018 Sociedade Brasileira de Pneumologia e Tisiologia https://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License |
| spellingShingle | Letter to the Editor da Cunha, Fernanda Sales Valle, Solange Oliveira Rodrigues Elabras, José Dortas, Sérgio Duarte França, Alfeu Tavares Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis |
| title | Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis |
| title_full | Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis |
| title_fullStr | Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis |
| title_full_unstemmed | Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis |
| title_short | Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis |
| title_sort | omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467590/ https://www.ncbi.nlm.nih.gov/pubmed/30517345 http://dx.doi.org/10.1590/S1806-37562017000000325 |
| work_keys_str_mv | AT dacunhafernandasales omalizumabasaddontherapyinpatientswithasthmaandallergicbronchopulmonaryaspergillosis AT vallesolangeoliveirarodrigues omalizumabasaddontherapyinpatientswithasthmaandallergicbronchopulmonaryaspergillosis AT elabrasjose omalizumabasaddontherapyinpatientswithasthmaandallergicbronchopulmonaryaspergillosis AT dortassergioduarte omalizumabasaddontherapyinpatientswithasthmaandallergicbronchopulmonaryaspergillosis AT francaalfeutavares omalizumabasaddontherapyinpatientswithasthmaandallergicbronchopulmonaryaspergillosis |